Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>
2020 · Clinical Cancer Research · 145 citations
https://doi.org/10.1158/1078-0432.ccr-20-3139
L
Linda Pestano
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
1.3K
Citations
15
h-index
17
i10-index
Linda Pestano is an academic researcher from Ensysce Biosciences (United States). The author has contributed to research in topics: MicroRNA in disease regulation & Cutaneous lymphoproliferative disorders research & Protein Degradation and Inhibitors. The author has an h-index of 15, co-authored 38 publications.
Papers by this author
worksClinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers
2024 · Clinical and Translational Science · 3 citations
https://doi.org/10.1111/cts.13765
Formulation development and a Phase 1 clinical study of PF614-MPAR, an oxycodone prodrug with oral opioid overdose protection
2026 · Journal of Opioid Management · 0 citations
https://doi.org/10.5055/jom.0991
Appendix: Formulation development and a Phase 1 clinical study of PF614-MPAR, an oxycodone prodrug with oral opioid overdose protection
2026 · Journal of Opioid Management · 0 citations
https://doi.org/10.5055/jom.0991-appendix
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat